Daratumumab for Immunoglobulin Light Chain Amyloidosis

Foteini Theodorakakou; Meletios A Dimopoulos; Efstathios Kastritis

doi:10.17925/ohr.2021.17.2.79

Back

Shared by

Meletios A Dimopoulos

Daratumumab for Immunoglobulin Light Chain Amyloidosis

Article 2021 en

Authors

FT
Foteini Theodorakakou
Meletios A Dimopoulos
EK
Efstathios Kastritis

Related publications

Article2021

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

Efstathios Kastritis, Giovanni Palladini, Monique C. Minnema, Ashutosh Wechalekar, Arnaud Jaccard, Hans C. Lee, Vaishali Sanchorawala, Simon Gibbs, Peter Mollee, Christopher P. Venner, Jin Lu, Stefan Schönland, Moshe E. Gatt, Kenshi Suzuki, Kihyun Kım, M. Teresa Cibeira, Meral Beksaç, Edward N. Libby, Jason Valent,

Abstract

1 min read

<p/>

Discussion(0)

Sign in to like and join the discussion.

No comments yet. Be the first to comment.

Vânia Hungria,

Sandy W. Wong,

Michael Rosenzweig,

Naresh Bumma,

Antoine Huart,

Meletios A Dimopoulos,

Divaya Bhutani,

Adam Waxman,

Stacey Goodman,

Jeffrey A. Zonder,

Selay Lam,

Kevin Song,

Timon Hansen,

Morten Salomo,

Wilfried Roeloffzen,

Krzysztof Jamroziak,

Fiona Kwok,

Chihiro Shimazaki,

Jin Seok Kim,

Edvan Crusoé,

Tahamtan Ahmadi,

NamPhuong Tran,

Xiang Qin,

Sandra Y. Vasey,

Brenda Tromp,

Jordan M. Schecter,

Brendan M. Weiss,

Sen Hong Zhuang,

Jessica Vermeulen,

Giampaolo Merlini,

Raymond L. Comenzo

Article2024

Graded Organ Response and Progression Criteria for Kidney Immunoglobulin Light Chain Amyloidosis

Eli Muchtar, Brendan Wisniowski, Susan Geyer, Giovanni Palladini, Paolo Milani, Giampaolo Merlini, Stefan Schönland, Kaya Veelken, Ute Hegenbart, Nelson Leung, Angela Dispenzieri, Shaji Kumar, Efstathios Kastritis, Meletios A Dimopoulos, Michaela Liedtke, Patricia Ulloa, Vaishali Sanchorawala, Raphaël Szalat, Katharine Dooley, Heather Landau, Erica Petrlik, Suzanne Lentzsch, Alexander Coltoff, Joan Bladé, María Teresa Cibeira, Oliver C. Cohen, Darren Foard, Jullian Gillmore, Helen J. Lachmann, Ashutosh Wechalekar, Morie A. Gertz

Article2021

Daratumumab plus CyBorD for patients with newly diagnosed light chain (AL) amyloidosis

Foteini Theodorakakou, Meletios A Dimopoulos, Efstathios Kastritis

Article2012

New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes

Giovanni Palladini, Angela Dispenzieri, Morie A. Gertz, Shaji Kumar, Ashutosh Wechalekar, Philip N. Hawkins, Stefan Schönland, Ute Hegenbart, Raymond L. Comenzo, Efstathios Kastritis, Meletios A Dimopoulos, Arnaud Jaccard, Catherine Klersy, Giampaolo Merlini

Article2022

The utility of splenic imaging parameters in cardiac magnetic resonance for the diagnosis of immunoglobulin light-chain amyloidosis

Niki Lama, Αlexandros Briasoulis, Efstratios Karavasilis, Κimon Stamatelopoulos, Angeliki Chasouraki, Efthymia Alexopoulou, Stavros Spiliοpoulos, Foteini Theodorakakou, Meletios A Dimopoulos, Efstathios Kastritis, Nikolaos Kelekis